BioSpace News Archive

Bio NC

Clinical Catch-Up: January 10-14

Heading into the middle of January, companies announced plenty of new clinical trial news. Here’s a look.

January 14, 2022
·
6 min read
·
Mark Terry
Business

Flagship’s Afeyan Outlines Biotech’s Top 4 Trends

Today, Noubar Afeyan, founder of Flagship Pioneering, published the platform development company’s 2022 Annual Letter, and in it, outlined what he sees as the four top forces shaping the future of biotech.

January 14, 2022
·
3 min read
·
Mark Terry
Business

JPM Day 4: Battered Emergent Solutions Looks Ahead, Vir and Thermo Fisher

Emergent BioSolutions, Vir Biotechnology and Thermo Fisher, come into 2022 with reports of new opportunities, new vaccines, and partnership expansions.

January 14, 2022
·
3 min read
·
Alex Keown
Business

Cancer Research Legend Beatrice Mintz Gone at 100

Beatrice Mintz, the research legend passed away at the age of 100. Her contribution to the field is unforgettable. ere’s more about her and the research.

January 14, 2022
·
2 min read
·
Kaylei Whalen
Drug Development

Novel Vaccines with Novel Targets Emerge at Biotech Showcase

Vaccine development is experiencing a resurgence in the wake of the COVID-19 pandemic, with companies developing a variety of approaches.

January 14, 2022
·
4 min read
·
Gail Dutton
Business

Relief Responds, Says NRx COVID-19 Collab Still in Place

Relief said that NRx’s claims that their partnership has been canceled were untrue and that it believes their collaboration involving aviptadil remains active and in full force.

January 14, 2022
·
2 min read
·
Vanessa Doctor, RN
Genetown

New Evidence Adamently Suggests Epstein-Barr Virus Triggers MS

New research from Harvard University strongly suggests that infection with the Epstein-Barr virus is the leading cause of multiple sclerosis in most patients.

January 14, 2022
·
3 min read
·
Kate Goodwin
Drug Development

UCLA “Kick and Kill” Approach Shows Early Promise in Treating HIV

Researchers from UCLA believe they may have a possible new approach to treating, and potentially eradicating HIV.

January 14, 2022
·
2 min read
·
Alex Keown
FDA

Newly Discovered Gene Doubles Severe COVID-19 Risk and WHO Updates Guidelines

Researchers from the Medical University of Bialystok in Poland identified a gene that appears to double the risk of severe COVID-19.

January 14, 2022
·
5 min read
·
Mark Terry
Drug Development

New Cell Therapy Player Makes Public Debut at JPM

Affini-T Therapeutics unveiled its mission to target oncogenic driver mutations to deliver transformative therapies intended to cure patients.

January 14, 2022
·
2 min read
·
Alex Keown